In vivo effects of deoxyspergualin (NKT-01) on lymphocyte activation in response to alloantigens. 1988

Y Yoshikawa, and H Uchida, and H Kuroda, and T Nakamura, and A Obayashi, and A Fujii, and T Takeuchi
Central Research Laboratories, Takara Shuzo Co., Ltd., Shiga, Japan.

We studied the effects of deoxyspergualin (NKT-01) on the events of lymphocyte activation in vivo by inoculating mice in the footpad with allogeneic spleen cells, and compared the effects with those of cyclosporin A (CyA). The administration of NKT-01 increased the numbers of cells recovered from the popliteal lymph node (PLN) 7 days after inoculation, but inhibited the proliferation of these cells in the presence of exogenous interleukin 2 (IL-2). NKT-01 enhanced IL-2 production, but suppressed the production of macrophage activating factor (MAF) in the mixed lymphocyte reaction between the PLN cells and allogeneic spleen cells treated with mitomycin C. CyA decreased the numbers of PLN cells little, and suppressed the response to exogenous IL-2 and the production of both IL-2 and MAF. Results with tumor cells used as allogeneic cells suggested that there was a close relationship between the suppression of MAF production by NKT-01 and its inhibition of allograft rejection. The findings showed that NKT-01 inhibited both the MAF production by and the response to IL-2 of PLN cells, and that these effects were involved in the suppression of allograft rejection by NKT-01.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D007519 Isoantigens Antigens that exist in alternative (allelic) forms in a single species. When an isoantigen is encountered by species members who lack it, an immune response is induced. Typical isoantigens are the BLOOD GROUP ANTIGENS. Alloantigens,Alloantigen,Isoantigen
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008222 Lymphokines Soluble protein factors generated by activated lymphocytes that affect other cells, primarily those involved in cellular immunity. Lymphocyte Mediators,Mediators, Lymphocyte
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D003524 Cyclosporins A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. Cyclosporines
D005260 Female Females
D006146 Guanidines A family of iminourea derivatives. The parent compound has been isolated from mushrooms, corn germ, rice hulls, mussels, earthworms, and turnip juice. Derivatives may have antiviral and antifungal properties.

Related Publications

Y Yoshikawa, and H Uchida, and H Kuroda, and T Nakamura, and A Obayashi, and A Fujii, and T Takeuchi
October 1988, The Journal of antibiotics,
Y Yoshikawa, and H Uchida, and H Kuroda, and T Nakamura, and A Obayashi, and A Fujii, and T Takeuchi
February 1977, Cellular immunology,
Y Yoshikawa, and H Uchida, and H Kuroda, and T Nakamura, and A Obayashi, and A Fujii, and T Takeuchi
December 1987, Journal of immunology (Baltimore, Md. : 1950),
Y Yoshikawa, and H Uchida, and H Kuroda, and T Nakamura, and A Obayashi, and A Fujii, and T Takeuchi
July 1983, Veterinary immunology and immunopathology,
Y Yoshikawa, and H Uchida, and H Kuroda, and T Nakamura, and A Obayashi, and A Fujii, and T Takeuchi
October 1989, Transplantation proceedings,
Y Yoshikawa, and H Uchida, and H Kuroda, and T Nakamura, and A Obayashi, and A Fujii, and T Takeuchi
June 1996, Transplantation proceedings,
Y Yoshikawa, and H Uchida, and H Kuroda, and T Nakamura, and A Obayashi, and A Fujii, and T Takeuchi
December 1992, Immunology letters,
Y Yoshikawa, and H Uchida, and H Kuroda, and T Nakamura, and A Obayashi, and A Fujii, and T Takeuchi
December 1973, Transplantation proceedings,
Y Yoshikawa, and H Uchida, and H Kuroda, and T Nakamura, and A Obayashi, and A Fujii, and T Takeuchi
February 1995, Transplantation proceedings,
Y Yoshikawa, and H Uchida, and H Kuroda, and T Nakamura, and A Obayashi, and A Fujii, and T Takeuchi
January 1995, Cancer chemotherapy and pharmacology,
Copied contents to your clipboard!